Similar articles

• Restoration of allogeneic responsiveness of lymphocytes from cyclosporin A-treated animals with interleukin 2.

  Wang BS, Heacock EH, Zheng CX, Tilney NL, Mannick JA. Wang BS, et al. Transplantation. 1982 Apr;33(4):454-6. Transplantation. 1982. PMID: 6978560 No abstract available.
• Specific adoptive therapy of established leukemia with syngeneic lymphocytes sequentially immunized in vivo and in vitro and nonspecifically expanded by culture with Interleukin 2.

  Cheever MA, Greenberg PD, Fefer A. Cheever MA, et al. J Immunol. 1981 Apr;126(4):1318-22. J Immunol. 1981. PMID: 6970768 No abstract available.
• Modulation of T lymphocyte proliferation in mice infected with Schistosoma mansoni: VIP suppresses mitogen- and antigen-induced T cell proliferation possibly by inhibiting IL-2 production.

  Metwali A, Blum A, Mathew R, Sandor M, Lynch RG, Weinstock JV. Metwali A, et al. Cell Immunol. 1993 Jun;149(1):11-23. doi: 10.1006/cimm.1993.1132. Cell Immunol. 1993. PMID: 8099848
• A lymphocyte growth factor made by a human lymphoid cell line.

  Sanderson R, Vesole D, Jakway J, Talmage D. Sanderson R, et al. Immunol Rev. 1980;51:177-91. doi: 10.1111/j.1600-065x.1980.tb00321.x. Immunol Rev. 1980. PMID: 7000670 Review. No abstract available.
• T-T cell interactions during cytotoxic T lymphocyte (CTL) responses: T cell derived helper factor (Interleukin 2) as a probe to analyze CTL responsiveness and thymic maturation of CTL progenitors.

  Wagner H, Hardt C, Heeg K, Pfizenmaier K, Solbach W, Bartlett R, Stockinger H, Röllinghoff M. Wagner H, et al. Immunol Rev. 1980;51:215-55. doi: 10.1111/j.1600-065x.1980.tb00323.x. Immunol Rev. 1980. PMID: 7000672 Review. No abstract available.